Abstract
This article demonstrates conclusively that systemic vasodilator therapy is an important new medical treatment for acute and chronic heart failure. Initially, vasodilators were used only when digitalis and diuretics could not adequately treat congestive heart failure. Now many clinicians view the vasodilators as equal or even better alternatives than digitalis and diuretics. There is no doubt that vasodilator therapy is one of the major advances in the treatment of heart failure.
摘要
相似文献
1
Vasodilator drugs.
Compr Ther. 1984 Feb;10(2):38-45.
2
Vasodilator therapy of congestive heart failure.充血性心力衰竭的血管扩张剂治疗
Adv Intern Med. 1980;26:293-315.
3
Guidelines for vasodilator therapy of congestive heart failure in infants and children.
Am Heart J. 1987 Apr;113(4):994-1005. doi: 10.1016/0002-8703(87)90062-7.
4
Vasodilators in the treatment of congestive heart failure.
Conn Med. 1983 Oct;47(10):614-8.
5
[Vasodilator agents in the treatment of heart failure].[血管扩张剂治疗心力衰竭]
G Ital Cardiol. 1978;8(1):1-11.
6
[Vasodilator agents in the treatment of cardiac insufficiency].
Ther Umsch. 1984 Feb;41(2):117-24.
7
Afterload reduction in the treatment of cardiac failure.心力衰竭治疗中的后负荷降低
Schweiz Med Wochenschr. 1978 Nov 4;108(44):1695-703.
8
[Treatment of cardiac failure with vasodilators (author's transl)].血管扩张剂治疗心力衰竭（作者译）
Schweiz Rundsch Med Prax. 1978 May 30;67(22):219-29.
9
[Vasodilators in heart failure? Basic principles and its role in practice].
Dtsch Med Wochenschr. 1981 Sep 25;106(39):1263-6. doi: 10.1055/s-2008-1070494.
10
[Treatment of heart failure with vasodilators].
Internist (Berl). 1980 Dec;21(12):753-9.
Zotero 插件